[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 2009

Psychoneuro-oncologyIts Time Has Arrived

Arch Dermatol. 2009;145(12):1439-1442. doi:10.1001/archdermatol.2009.306

The notion that emotions may be associated with the development and progression of cancer is not new; indeed, this assumption was held for many centuries1 with scant scientific data to support it. During recent decades, numerous clinical and basic laboratory studies have provided evidence in support of the concept that biopsychosocial factors can influence malignant disease in animal models as well as in humans. The relevance of these investigations lies in the possibility of developing therapeutic strategies for patients with cancer that rely on psychological as well as psychoneuro-immunological principles in addition to traditional chemotherapeutic, radiation, and immunologically based treatments.

First Page Preview View Large
First page PDF preview
First page PDF preview
×